Related Experiment Video
Updated: Jun 14, 2025

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Ketamine - An Imperfect Wonder Drug?
Tanner Magruder1, Marielle Isenhart1, Maximillian V Striepe1
1Department of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Ketamine, a dissociative anesthetic, offers benefits beyond anesthesia for pain and depression. This review explores its diverse clinical applications and potential for abuse.
Area of Science:
- Anesthesiology
- Pharmacology
- Psychiatry
Background:
- Ketamine, developed in the 1960s as an alternative to phencyclidine (PCP), is a potent sedative and dissociative anesthetic.
- It was initially favored for its lower incidence of severe side effects compared to PCP, particularly hallucinations.
- Its rapid induction and recovery properties made it valuable in emergency medicine and surgery.
Purpose of the Study:
- To review the diverse clinical and non-clinical applications of ketamine.
- To explore ketamine's impact on patient care beyond its anesthetic properties.
- To examine ketamine's established and emerging therapeutic uses, including pain management and psychiatric disorders.
Main Methods:
- Literature review of clinical studies and pharmacological data.
- Analysis of historical and current medical applications of ketamine.
- Examination of ketamine's mechanism of action and side effect profiles.
Main Results:
- Ketamine is effective for acute and chronic pain management.
- It shows promise in treating psychiatric conditions like major depression.
- Ketamine is also recognized as a drug of abuse due to its psychoactive effects.
Conclusions:
- Ketamine possesses a broad spectrum of clinical utility extending beyond anesthesia.
- Its therapeutic potential in pain and mental health warrants further investigation.
- Understanding both clinical benefits and risks of ketamine is crucial for patient care.
More Related Videos
10:32A Guide to In vivo Single-unit Recording from Optogenetically Identified Cortical Inhibitory Interneurons
Published on: November 7, 2014
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Electroconvulsive Therapy
Sedatives and Hypnotics Drugs: Barbiturates
Depolarizing Blockers: Pharmocokinetics